| answer text |
<p>Since April 1 2013 NHS England has been responsible for commissioning Alternative
and Augmentative Communication (AAC) aids for patients with complex disability whose
needs require specialised assessment, including for patients with motor neurone disease
(MND). Commissioning of non-specialised AAC aids is the responsibility of local clinical
commissioning groups.</p><p> </p><p> </p><p> </p><p>NHS England has published a service
specification for specialised AAC aids that sets out what should be in place for providers
to offer evidence-based, safe and effective services and supports equity of access
to a nationally consistent, high quality service for patients across the country including
in Surrey and Sussex. The specification can be found at:</p><p> </p><p> </p><p> </p><p>www.england.nhs.uk/wp-content/uploads/2013/06/d01-com-dis-equ-alt-aug-comm-aids.pdf</p><p>
</p><p> </p><p> </p><p> </p><p> </p><p>NHS England has identified an additional £22.5
million funding for AAC and Environmental Controls in 2014-15. They have been working
closely with the Motor Neurone Disease Association (MNDA) to ensure this funding is
equitably distributed across England in a fair and consistent manner. The MNDA are
representing all patients on the panel which is reviewing this funding allocation.</p><p>
</p><p> </p><p> </p>
|
|
